ADAPT PHARMA INC.

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2016–2022

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2022	—	2	1
2021	—	4	1
2020	—	4	1
2019	—	4	1
2018	—	4	1
2017	—	5	1
2016	—	3	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
FORBES-TATE	—	26

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	11
SENATE	11
Justice, Dept of (DOJ)	7
Centers For Disease Control & Prevention (CDC)	3
Health & Human Services, Dept of (HHS)	3
Office of Management & Budget (OMB)	3
Office of Natl Drug Control Policy (NDCP)	3
Substance Abuse & Mental Health Services Administration (SAMHSA)	3

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	12

Bills Explicitly Cited (6)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 6157115th Congress

Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019

2018 · fourth_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to CARA implementation; Issues related to opioid abuse; Issues related to FDA; Issues related to FY 2018 Appropriations implementation; Issues related FY 2019 LHHS Appropriations (H.R. 6470, S.3158, H.R. 6157 Labor/HHS/Education Appropriations Act of 2019, and Continuing Appropriations Act, 2019); Issues related to CDC; Issues related to HHS; Issues related to DOJ; Issues related to funding for community-based nalaxone; Issues related to ONDCP funding.

Client expense: — · Firm income: $100,000

Matched citations: H.R. 6157

H.R. 6470115th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019

2018 · fourth_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to CARA implementation; Issues related to opioid abuse; Issues related to FDA; Issues related to FY 2018 Appropriations implementation; Issues related FY 2019 LHHS Appropriations (H.R. 6470, S.3158, H.R. 6157 Labor/HHS/Education Appropriations Act of 2019, and Continuing Appropriations Act, 2019); Issues related to CDC; Issues related to HHS; Issues related to DOJ; Issues related to funding for community-based nalaxone; Issues related to ONDCP funding.

Client expense: — · Firm income: $100,000

Matched citations: H.R. 6470

S. 3158115th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019

2018 · fourth_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to CARA implementation; Issues related to opioid abuse; Issues related to FDA; Issues related to FY 2018 Appropriations implementation; Issues related FY 2019 LHHS Appropriations (H.R. 6470, S.3158, H.R. 6157 Labor/HHS/Education Appropriations Act of 2019, and Continuing Appropriations Act, 2019); Issues related to CDC; Issues related to HHS; Issues related to DOJ; Issues related to funding for community-based nalaxone; Issues related to ONDCP funding.

Client expense: — · Firm income: $100,000

Matched citations: S.3158

S. 524114th Congress

Comprehensive Addiction and Recovery Act of 2016

2016 · fourth_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to CARA (Comprehensive Addiction and Recovery Act, S. 524.); Issues related to opioid abuse; Issues related to FDA.

Client expense: — · Firm income: $60,000

Matched citations: S. 524

Show 2 more cited filings

S. 524114th Congress

Comprehensive Addiction and Recovery Act of 2016

2016 · third_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to CARA (Comprehensive Addiction and Recovery Act, S. 524).

Client expense: — · Firm income: $20,000

Matched citations: S. 524

S. 524114th Congress

Comprehensive Addiction and Recovery Act of 2016

2016 · third_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to CARA (Comprehensive Addiction and Recovery Act, S. 524).

Client expense: — · Firm income: —

Matched citations: S. 524

Source: Senate LDA

ADAPT PHARMA INC. — Lobbying Disclosure | Poliscope